pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Marketed
    secukinumab
    Cosentyx (secukinumab)
    Hidradenitis Suppurativa$NVS NOVARTIS AG
  • Phase 2
    secutrelvir
    secutrelvir [INN]
    Coronavirus Disease 2019 (COVID-19)$SGIOF SHIONOGI & CO LTD
  • Phase 3
    sefaxersen sodium
    sefaxersen sodium
    IgA Nephropathy (Berger's Disease) F. Hoffmann-La Roche Ltd
← prev
page 216 of 231
next →
Pain89
Neurology1
Phase 3
selatogrel
selatogrel [INN]
Myocardial Infarction
Idorsia Pharmaceutical Ltd
  • Phase 2
    selcodebart
    selcodebart [INN]
    Anemia$IRON Disc Medicine, Inc.
  • Marketed
    selegiline ER
    Emsam (selegiline)
    Major Depressive Disorder Mylan Specialty LP
  • Marketed
    selegiline hydrochloride
    Selegiline Hydrochloride
    Parkinson's Disease i3 Pharmaceuticals LLC
  • Phase 3
    selenium sulfide
    Selenium Sulfide (selenium sulfide [USP])
    Meibomian Blepharitis Azura Ophthalmics Pty Ltd
  • Phase 3
    seltorexant
    seltorexant
    Insomnia$JNJ JOHNSON & JOHNSON
  • Phase 2
    semzuvolimab
    semzuvolimab [INN]
    Human Immunodeficiency Virus (HIV) Infections (AIDS) United BioPharma Inc
  • Phase 2
    sepantronium bromide
    sepantronium bromide
    Burkitt Lymphoma Beijing zhikangbo Medical Oncology Research Co Ltd
  • Phase 2
    sepetaprost
    sepetaprost [INN]
    Ocular Hypertension Santen Pharmaceutical Co Ltd
  • Marketed
    sepiapterin
    Sephience (sepiapterin)
    Hyperphenylalaninemia$PTC PTC INC.
  • Phase 3
    seralutinib
    seralutinib
    Pulmonary Arterial Hypertension$GOSS Gossamer Bio, Inc.
  • Marketed
    sertaconazole nitrate
    Ertaczo (sertaconazole nitrate)
    Tinea Pedis (Athlete Foot) Bausch Health Americas Inc
  • Phase 2
    setanaxib
    setanaxib [INN]
    Primary Biliary Cholangitis (Primary Biliary Cirrhosis) Calliditas Therapeutics AB
  • Phase 3
    setrusumab
    setrusumab
    Osteogenesis Imperfecta$RARE Ultragenyx Pharmaceutical Inc.
  • Phase 3
    sevasemten
    sevasemten
    Becker Muscular Dystrophy$EWTX Edgewise Therapeutics, Inc.
  • Marketed
    sevelamer hydrochloride
    Sevelamer Hydrochloride Winthrop (sevelamer hydrochloride)
    Hyperphosphatemia In Chronic Kidney Disease Winthrop US
  • Phase 2
    seviprotimut-L
    seviprotimut-L
    Melanoma Polynoma LLC
  • Marketed
    short ragweed pollen (Ambrosia artemisiifolia) allergen extract ODT
    Ragwitek
    Ragweed Pollen Allergy ALK-Abello Inc
  • Phase 2
    siG-12D-LODER
    Pancreatic Ductal Adenocarcinoma$SLXN Silexion Therapeutics Corp
  • Phase 2
    silevertinib
    silevertinib
    Non-Small Cell Lung Cancer$BDTX Black Diamond Therapeutics, Inc.
  • Phase 2
    silmitasertib
    silmitasertib [INN]
    Bile Duct Cancer (Cholangiocarcinoma) Senhwa Biosciences Inc
  • Marketed
    silodosin
    Silodosin (silodosin [INN])
    Storage Symptoms of Benign Prostatic Hyperplasia Creekwood Pharmaceutical Inc
  • Marketed
    siltuximab
    Sylvant (siltuximab)
    Giant Lymph Node Hyperplasia (Castleman's Disease) Recordati Corp
  • Marketed
    silver sulfadiazine
    Thermazene (silver sulfadiazine)
    Bacterial Sepsis Mallinckrodt LLC
  • Phase 3
    simoladagene autotemcel
    simoladagene autotemcel
    Adenosine Deaminase (ADA) Deficiency Related SCID Rarity PBC
  • Marketed
    sinecatechins
    Veregen (sinecatechins)
    Genital Warts (Condylomata Acuminata)$ANIP ANI PHARMACEUTICALS INC
  • Phase 2
    sintilimab
    sintilimab
    Angiosarcoma Innovent Biologics Inc